Search results
Author(s):
Ankit Agrawal
,
Toshiaki Isogai
,
Shashank Shekhar
,
et al
Added:
1 year ago
Author(s):
Kengo Kusano
Added:
1 week ago
ACC.24 — We are joined by Dr Kengo Kusano (National Cerebral and Cardiovascular Center, JP) to discuss the findings from the Embo-Abl Study.Embo-Abl is a multicenter prospective randomized study which aims to compare the incidence of periprocedural cerebral embolisms caused by catheter ablation of atrial fibrillation (AF) between cryoballoon and radiofrequency ablation. 230 patients with AF from…
View more
Author(s):
Marat Fudim
Added:
1 year ago
Dr Marat Fudim (Duke University School of Medicine, NC, US) joins us on-site at Heart Failure 2022 to outline the findings of REBALANCE-HF Roll In Cohort (NCT04592445).
In this study, patients with heart failure with preserved ejection fraction (HFpEF) were randomized 1:1 to receive either ablation of the right greater splanchnic nerve (GSN) or sham at the time of the procedure. The study aimed…
View more
Author(s):
Giovanni Torsello
,
Konstantinos P Donas
Added:
3 years ago
Stroke is a leading cause of death and disability in the developed world.1 More than 750,000 strokes occur in the US annually,1 and one-third of these patients die during the first few months after their strokes. Acute carotid syndrome (ACS) is defined as a set of signs and symptoms linked to neurological deficits (transient ischemic attack [TIA] or ischemic stroke) caused by carotid occlusive…
View more
Author(s):
Mirvat Alasnag
,
Waqar Ahmed
,
Ibrahim Al-Nasser
,
et al
Added:
2 years ago
Embolic Protection
Author(s):
Jennifer Franke
,
Horst Sievert
Added:
3 years ago
Article
Author(s):
Vijay Kunadian
,
Richard J Jabbour
,
Rajesh Kharbanda
Added:
1 year ago
ACI 2023 — Prof Vijay Kunadian (Newcastle upon Tyne Hospitals NHS Trust, UK) joined by Prof Raj Kharbanda (John Radcliffe Hospital, Oxford, UK), lead researcher of BHF PROTECT-TAVI trial, and Dr Richard J Jabbour (University Hospital Southampton NHS FT, UK) to discuss the use of embolic protection devices in 2023.
This insightful discussion covers various aspects of the topic of embolic…
View more
Author(s):
Samir R Kapadia
Added:
1 year ago
TCT 22 - In this short interview, Dr Samir Kapadia (Cleveland Clinic, OH, US) outlines the findings of the PROTECTED-TAVR trial, which aimed to demonstrate the performance of Boston Scientific's Sentinel® Cerebral Protection System in transcatheter aortic valve replacement.
In this study, 3000 patients were randomized to receive either TAVR with the Sentinel system or TAVR without intervention…
View more
Author(s):
Christopher J White
Added:
3 years ago
More than three-quarters of a million Americans will suffer a stroke this year. Stroke ranks as the third most common cause of death after heart disease and cancer. It is the number one cause of disability among adults and the main reason for rehabilitation. Many, but not all, strokes are related to atherosclerosisÔÇöthe same disease that causes heart attacks. Blockage of one of the two main…
View more
Nicolas M Van Mieghem
Job title: Medical Director
Author